SKP2 and cancer: Yoshida et al. found that the inhibition of cancer cell proliferation is mediated by S-phase kinase-associated protein 2 (SKP2) targeting p27kip1 [34], which suggests that different molecules might be involved in the suppression of cell growth by RECK in a cell-specific manner.